HC Wainwright Reiterates Buy Rating on Sophia Genetics, Sets $14 Target
HC Wainwright reiterated its Buy rating on Sophia Genetics with a $14 price target. The target implies 88.9% upside from the Oct. 9 close of $7.41.
Story updates
11:38:21 AM UTC
SquawkNews
SOPHiA GENETICS Price Target Maintained With a $14.00/Share by HC Wainwright & Co.